$NIKI News

Niki BioSolutions Enters into Strategic Agreement to Provide APOE Testing Services for Progressive Medical Research (PMR)

Niki BioSolutions’ DiamiR Biosciences Agrees To Provide Progressive Medical Research With Apolipoprotein E Genotyping Services In Support Of Ongoing Clinical And Translational Research Programs

Niki BioSolutions Shares Halted On Circuit Breaker To The Upside, Stock Now Up 13.36%

Aptorum Group Announces 1-For-10 Reverse Stock Split, Effective July 20; Proposed Merger With DiamiR Biosciences Anticipated To Close Around July 20

Aptorum Group Announces Collaboration Between DiamiR And AlzLabs Precision Diagnostics To Generate Protein And MicroRNA Blood-Based Biomarker Data With Focus On Alzheimer's Disease

THE Mining Investment Event 2026 Announces Keynote Speakers and Panels, Additional Sponsors and Participating Companies

New Forecasts: Here's What Analysts Think The Future Holds For Andean Precious Metals Corp. (TSE:APM)

Andean Precious Metals Appoints Victor Flores as Senior Vice President, Exploration, Operations and Growth

Andean Precious Metals Reports Strong First Quarter 2026 Production Results

We Believe Andean Precious Metals' (TSE:APM) Earnings Are A Poor Guide For Its Profitability

Exploring Canada's Undiscovered Gems This March 2026

Is It Too Late To Consider Andean Precious Metals (TSX:APM) After Last Year’s 291.9% Surge?

Andean Advises of Senior Management Change

Andean Precious Metals Q4 Earnings Call Highlights

Andean Precious Metals Reports Fourth Quarter and Year-End 2025 Financial Results

Andean Precious Metals ETF Inclusion Highlights Valuation Gap And Recent Weakness

Andean Precious Metals Announces Inclusion in VanEck Junior Gold Miners ETF (GDXJ)

Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania

Aptorum Group And DiamiR Biosciences Announce Publication Of Paper Showing Feasibility Of Detecting Glioblastoma Through Blood Plasma Tests

Aptorum Group And DiamiR Biosciences Announce Publication Of Paper Showing Feasibility Of Detecting Glioblastoma Through Blood Plasma Tests